文献速递甲状腺与浅表US

聚桂醇注射消融治疗良性囊性为主甲状腺结节的疗效及相关因素:一项前瞻性研究

Efficacy of Lauromacrogol Injection for Ablation of Benign Predominantly Cystic Thyroid Nodules and Related Factors: A Prospective Study.
PubMed 文献 · Korean J Radiol · 2022-01-01

前瞻性研究纳入137例患者共142个良性囊性为主甲状腺结节,行聚桂醇注射消融(LIA),12个月随访有效治疗率73.2%(104/142),末次随访复发率12.0%(17/142)。结节实性成分内2-3级血流是治疗无效的唯一独立因素(OR 3.054,95%CI 1.148-8.127,p=0.025)。

要点

  • 12个月随访结节体积缩小率≥50%视为有效,本组有效治疗率73.2%(104/142)。
  • 实性成分内2-3级血流是LIA无效的唯一独立因素,OR 3.054(95%CI 1.148-8.127,p=0.025)。
  • 末次随访复发率12.0%(17/142),中位随访32±11个月(范围12-54个月)。

核心结论

  • LIA是囊性为主甲状腺结节的有效治疗方法;结节实性成分内2-3级血流是LIA无效的唯一独立危险因素。

研究设计与样本

  • 前瞻性研究,137例患者共142个经细胞学证实良性的囊性为主甲状腺结节(中位体积12.5 mL,范围0.4-156 mL),行聚桂醇注射消融,治疗后1、3、6个月及之后每6个月随访结节体积缩小率和美容评分。

诊断标准与关键数值

  • 12个月随访时结节体积缩小率≥50%定义为有效治疗,<50%定义为无效治疗;实性成分内2-3级血流(参照0-1级)与无效治疗相关,OR 3.054(95%CI 1.148-8.127,p=0.025)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To prospectively evaluate the efficacy of lauromacrogol injection for ablation (LIA) of benign predominantly cystic thyroid nodules and its related factors.

MATERIALS AND METHODS: A total of 142 benign predominantly cystic thyroid nodules (median volume, 12.5 mL; range, 0.4-156 mL) in 137 patients (male:female sex ratio, 36:101; mean age ± standard deviation [SD], 49 ± 13 years) were treated with LIA after being confirmed as benign via cytology. The volume reduction rate (VRR) of the nodules and cosmetic score were evaluated during follow-up at 1, 3, and 6 months after treatment and every 6 months thereafter. A VRR of ≥ 50% at the 12-month follow-up was considered to indicate effective treatment. The associations between the clinical factors and nodular ultrasound features, including the initial nodule volume, proportion of solid components, vascularity grade and ineffective treatment (VRR of < 50% at the 12-month follow-up), and regrowth were analyzed.

RESULTS: All patients completed follow-up for at least 12 months. The average ± SD follow-up period was 32 ± 11 months (range, 12-54 months). The effective treatment rate was 73.2% (104/142), while the regrowth rate was 12.0% (17/142) at the last follow-up. Grade 2-3 intranodular vascularity in the solid components of the nodules was the only independent factor associated with ineffective treatment, with an odds ratio (reference category, grade 0-1) of 3.054 (95% confidence interval, 1.148-8.127) (p = 0.025).

CONCLUSION: LIA is an effective treatment for predominantly cystic thyroid nodules. Grade 2-3 intranodular vascularity in the solid components of nodules is the only independent risk factor for ineffective LIA.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Dong YJ, Liu ZH, Zhou JQ, et al. Efficacy of Lauromacrogol Injection for Ablation of Benign Predominantly Cystic Thyroid Nodules and Related Factors: A Prospective Study. Korean J Radiol. 2022. PMID: 35345062. doi:10.3348/kjr.2020.1205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。